Vascular and hemodynamic differences between organic nitrates and nitrites

Journal of Pharmacology and Experimental Therapeutics

Volumn 280, Issue 1, 1997, Pages 326-331

  Bauer, John Anthony ^a,b   Nolan, Tim ^a   Fung, Ho Leung ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYL NITRITE; GLYCERYL TRINITRATE;

ANIMAL MODEL; ARTICLE; CARDIOVASCULAR DISEASE; DRUG EFFECT; DRUG POTENCY; DRUG TOLERANCE; HEMODYNAMIC MONITORING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

AMYL NITRITE; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; HEMODYNAMIC PROCESSES; MALE; NITRIC OXIDE; NITRITES; NITROGLYCERIN; RATS; RATS, SPRAGUE-DAWLEY; VASODILATION;

EID: 0030941560     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. AHLNER, J., AXELLSON, K. L., EKSTRAM-LJUSEGREN, M., FRIEDMAN, R. L., GRUNDSTROM, N., KARLSSON, J. O. G. AND ANDERSSON, R. G. G.: Relaxation of bovine mesenteric artery induced by glyceryl trinitrate is attenuated by pertussis toxin. Pharmacol. Toxicol. 62: 155-158, 1988.
2. BAUER, J. A., BOOTH, B. P. AND FUNG, H.-L.: Nitric Oxide Donors: Biochemical Pharmacology and Therapeutics. In Advances in Pharmacology Series: Nitric Oxide: Biochemistry, Molecular Biology, and Therapeutic Implications. ed. by L. Ignarro and F. Murad, pp. 361-381, Academic Press, San Diego, CA, 1995.
3. BAUER, J. A. AND FUNG, H.-L.: Effects of chronic glyceryl trinitrate on left ventricular haemodynamics in a rat model of congestive heart failure: Demonstration of a simple animal model for the study of in vivo nitrate tolerance. Cardiovase. Res. 24: 198-204, 1990.
4. BAUER, J. A. AND FUNG, H.-L.: Concurrent hydralazine administration prevents nitroglycerin-induced hemodynamic tolerance in experimental heart failure. Circulation 84: 35-39, 1991a.
5. BAUER, J. A. AND FUNG, H.-L.: Differential hemodynamic effects and tolerance properties of nitroglycerin and an S-nitrosothiol in experimental heart failure. J. Pharmacol. Exp. Ther. 256: 249-254, 1991b.
6. BAUER, J. A. AND FUNG, H.-L.: Specific binding of nitroglycerin to coronary artery microsomes: Evidence of a vascular nitrate binding site. Biochem. Pharmacol. 52: 619-625, 1996.
7. BAUER, J. A. AND FUNG, H.-L.: Effect of apparent elimination half-life on nitroglycerin-induced hemodynamic rebound in experimental heart failure. Pharm. Res. 10: 1341-1445, 1993b.
8. BAUER, J. A. AND FUNG, H.-L.: Non-nitrate nitric oxide donors. J. Myocard. Isch. 7: 17-22, 1995.
9. BAUER, J. A., GOPOLAKRISHNAN, M., TRIGGLE, D. J. AND FUNG, H.-L.: Continuous versus intermittent nitroglycerin administration in experimental heart failure: vascular relaxation and radioligand binding to adrenceptors and ion channels. J. Cardiovasc. Pharmacol. 22: 600-608, 1993.
10. BOESGAARD, S., ALDERSHVILE, J., POULSEN, H. E., LOFT, S., ANDERSON, M. E. AND MEISTER, A.: Nitrate tolerance in vivo is not associated with depletion of arterial of venous thiol levels. Circ. Res. 74: 115-120, 1994.
11. BRUNTON T. L.: On the use of nitrite of amyl in angina pectoris. Lancet 2: 97-98, 1867.
12. CHUNG, S.-J. AND FUNG, H.-L.: Identification of the subcellular site for nitroglycerin metabolism to nitric oxide in bovine coronary artery smooth muscle cells. J. Pharmacol. Exp. Ther. 253: 614-619, 1990.
13. CHUNG, S.-J. AND FUNG, H.-L.: Relationship between nitroglycerin-induced vascular relaxation and nitric oxide production. Probes with inhibitors and tolerance development. Biochem. Pharmacol. 45: 157-163, 1993.
14. CHUNG, S.-J., CHONG, S., SETH, P., JUNG, C. Y. AND FUNG, H.-L.: Conversion of nitroglycerin to nitric oxide in microsomes of the bovine coronary artery smooth muscle is not primarily mediated by glutathione-S-transferase. J. Pharmacol. Exp. Ther. 260: 652-659, 1992.
15. FEELISCH, M., BRANDS, F. AND KELM, M.: Human endothelial cells bioactivate organic nitrates to nitric oxide: Implications for the reinforcement of endothelial defence mechanisms, Eur. J. Clin. Invest. 25: 737-745, 1995.
16. FORSTER, S., WODITSCH I., SCHRODER, H. AND SCHROR, K.: Reduced nitric oxide release causes nitrate tolerance in the intact coronary circulation. J. Cardiovasc. Pharmacol. 17: 867-872, 1991.
17. FUNG, H.-L. AND BAUER, J. A.: Mechanisms of nitrate tolerance. Cardiovasc. Drugs Ther. 8: 265-275, 1994.
18. FUNG, H.-L., CHUNG, S.-J., CHONG, S., HOUGH, K., KAKEMI, M. AND KOWALUK, E. A.: Cellular mechanisms of nitrate action. Z. Kardiol. 78: 14-17, 1989.
19. GOGIA, H., MEHRA, A., PARIKH S., AJIT-UPPAL J., JOHNSON J. V. AND ELKAYAM U.: A randomized study to evaluate the effect of hydralazine on the development of nitrate tolerance in patients with heart failure. Circulation 92: 1601, 1995.
20. GREENBERG, H., DWYER, E. M., JAMESON, A. G. AND PINKERELL, B. M.: Effects of nitroglycerin on the major determinants of myocardial oxygen consumption. An angiographic and hemodynamic assessment. Am. J. Cardiol. 36: 426-432, 1975.
21. HAJ-YEHIA, A., AND BENET, L. Z.: Dissociation of tissue thiol content from nitroglycerin-induced cyclic-3′,5′-guanosine monophosphate and the state of tolerance: in vivo experiments in rats. J. Pharmacol. Exp. Ther. 273: 94-100, 1995.
22. IGNARRO, L. J., LIPPTON, H., EDWARDS, J. C., BARICOS, W. H., HYMAN, A. L., KADOWITZ, P. J. AND GRUETTER C. A.: Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: Evidence for the involvement of S-nitrosothiols as active intermediates. J. Pharmacol. Exp. Ther. 218: 739-749, 1981.
23. KOWALUK, E. A. AND FUNG, H.-L.: Vascular nitric oxide generating activities for organic nitrites and nitrates are distinct. J. Pharmacol. Exp. Ther. 259: 519-525, 1991.
24. LEIER, C. V., MAGORIEN, R. D., DESCH, C. E., THOMPSON, M. J. AND UNVERFERTH, D. V.: Hydralazine and isosorbide dinitrate: Comparative central and regional hemodynamic effects when administered alone or in combination. Circulation 63: 102-109, 1981.
25. LEMBO, N. J., DELL-ITALIA, L. J. AND CRAWFORD, M. H.: Bedside diagnosis of sytolic murmurs. N. Engl. J. Med. 318: 1572-1578, 1988.
26. MASSIE, B., CHATTERJEE, K., WERNER, J., GREENBERG, B., HART, R. AND PARMLEY, W. W.: Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure. Am. J. Cardiol. 40: 794-801, 1977.
27. MONCADA, S. AND HIGGS, A.: The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329: 2002-2012, 1993.
28. MUNZEL, T., SAYEGH, H., FREEMAN, B. A., TARPEY, M. M. AND HARRISON, D. G.: Evidence for enhanced vascular Superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross tolerance. J. Clin. Invest. 95: 187-194, 1995.
29. MURAD, F.: Cyclic guanosine monophosphate as mediator of vasodilation. J. Clin. Invest. 78: 1-5, 1986.
30. MURRELL W.: Nitroglycerin as a remedy for angina pectoris. Lancet 1: 80-81, 1879.
31. NEEDLEMAN, P. AND JOHNSON, E. M.: Mechanism of tolerance development to organic nitrates. J. Pharmacol. Exp. Ther. 184: 709-715, 1973.
32. NOACK, E. AND FEELISCH, M.: Molecular mechanisms of nitrovasodilator bioactivation. Bas. Res. Cardiol. 86: 37-50, 1991.
33. PFEFFER, M. A., PFEFFER, J. M., FISHBEIN, M. C., FLETCHER, P. J., SPADARO, J., KLONER, R. A. AND BRAUNWAUJ, E.: Myocardial infarct size and ventricular function in rats. Circ. Res. 44: 503-512, 1979.
34. SHAFFER, J. E., HAN, B.-J., CHERN, W. H. AND LEE, F. W.: Lack of tolerance to a 24-hr infusion of S-nitroso N-acetylpenicillamine in conscious rabbits. J. Pharmacol. Exp. Ther. 260: 286-293, 1992.
35. TORFGARD, K., AHLNER, J. AND AXELSSON, K. L.: Relaxation of bovine mesenteric arteries by glyceryl trinitrate and other nitro-compounds: Evidence for partly different mechanisms of action. Pharmacol. Toxicol. 67: 216-221, 1990.
36. ZIMMERMANN, T., LEITOLD, M. AND YEATES, R. A.: Comparison of isobutyl nitrate and isobutyl nitrite: Tolerance and cross tolerance to glyceryl trinitrate. Eur. J. Pharmacol. 192: 181-184, 1991.